Six months into a national study to see whether the cancer drug tamoxifen is useful in preventing breast cancer in women age 35 and older, it appears that young women with breast cancer in their immediate family are the most motivated to participate in the five-year study. Read More
Comments for: 16 Maine women join cancer drug study > EMMC participating in national research project on effects of tamoxifen
16 Maine women join cancer drug study > EMMC participating in national research project on effects of tamoxifen
You may also like
16 Maine women join cancer drug study > EMMC participating in national research project on effects of tamoxifen